Business
Here’s why Moderna’s coronavirus vaccine could outsell Pfizer’s

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
If you could get a coronavirus inoculation this afternoon, you probably wouldn’t care if the clinician told you that the shot might feel a bit chilly. But when it comes to hiring employees or judging which vaccine is going to sell better, it pays to know the difference between candidates that don’t need special help to keep their cool and those that need to be beyond ice-cold to have a chance at success.
Will Moderna Inc‘s (NASDAQ: MRNA) newly proven vaccine outperform its competitor made by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), which is likely to obtain regulatory approval and subsequently hit the market…
-
Noosa News12 hours ago
Reubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General10 hours ago
Police say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General18 hours ago
Queensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
Noosa News20 hours ago
Inquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family